Skip to content
HowShorted

Replimune Group, Inc. short interest in 2023

In 2023, Replimune Group, Inc.'s disclosed short interest ran from 3.34% of shares outstanding on 13 Jan 2023 to 14.71% on 29 Dec 2023, a change of +11.37 percentage points. The year's high was 14.94% on 29 Sep 2023 and its low 2.51% on 15 Feb 2023, averaging 10.91% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 20.87 days on 31 Aug 2023. Full history: Replimune Group, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Replimune Group, Inc. in 2023

2023 in figures

Start of year
3.34% (13 Jan 2023)
End of year
14.71% (29 Dec 2023)
Change
+11.37 pp
High
14.94% (29 Sep 2023)
Low
2.51% (15 Feb 2023)
Average
10.91%
Highest days to cover
20.87 (31 Aug 2023)
SEC filings marked
8

Every report in 2023

Replimune Group, Inc. short interest in 2023
SettlementShort interestDays to coverFilings since previous
13 Jan 20233.34%4.70
31 Jan 20232.80%2.97
15 Feb 20232.51%3.3410-Q filed, results (8-K)
28 Feb 20234.94%3.53
15 Mar 20236.71%6.47
31 Mar 202310.73%6.65
14 Apr 202311.26%12.71
28 Apr 202312.21%15.33
15 May 202312.29%20.04
31 May 202312.67%12.7110-K filed, results (8-K)
15 Jun 202312.93%9.61
30 Jun 202311.77%8.68
14 Jul 202311.70%16.83
31 Jul 202312.18%15.74
15 Aug 202313.15%13.0210-Q filed, results (8-K)
31 Aug 202313.84%20.87
15 Sep 202314.32%11.52
29 Sep 202314.94%13.82
13 Oct 202314.82%15.11
31 Oct 202314.78%15.09
15 Nov 202312.48%7.2010-Q filed, results (8-K)
30 Nov 202310.60%5.30
15 Dec 202310.09%1.60
29 Dec 202314.71%5.31

See also: Replimune Group, Inc.'s full history · most shorted US stocks of 2023 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.